Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet

@article{Sommer2015TreatmentOA,
  title={Treatment of Aspirin Exacerbated Respiratory Disease with a Low Salicylate Diet},
  author={D. D. Sommer and Stephanie Hoffbauer and Michael Au and Leigh J. Sowerby and Michael K. Gupta and Smriti Nayan},
  journal={Otolaryngology–Head and Neck Surgery},
  year={2015},
  volume={152},
  pages={42 - 47}
}
Objective Aspirin exacerbated respiratory disease (AERD) is comprised of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis. Treatment of this condition is challenging and may include topical/systemic steroids, endoscopic sinus surgery, and/or aspirin desensitization. Study Design A prospective crossover pilot study (n = 10) was conducted in which patients were randomized into either of 2 groups with 6 weeks of regular diet (R) or 6 weeks of a low salicylate… 
Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial
TLDR
A short-term low salicylate diet may not result in biochemical outcomes changes but seems to provide significant symptomatic relief for patients with AERD.
Aspirin-exacerbated respiratory disease and current treatment modalities
TLDR
Aspirin desensitization, Leukotriene-modifying agents, biologic agents, management of asthma, chronic rhinosinusitis, and nasal polyposis are recommended as treatment modalities, and investigational and dietary therapies are presented.
Effectiveness of Personalized Low Salicylate Diet in the Management of Salicylates Hypersensitive Patients: Interventional Study
TLDR
The results of this study indicate that the PLSD may have a positive effect in reducing symptoms of salicylate hypersensitivity and could be an additional tool supporting the therapy of these patients.
Salicylate Food Intolerance and Aspirin Hypersensitivity in Nasal Polyposis.
TLDR
Atopy and NSAID exacerbated respiratory disease can both be considered as predictors of NP recurrence and AERD and showed that salicylate food intolerance was associated with A ERD in nasal polyposis.
Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease.
  • Von Ta, A. White
  • Medicine
    The journal of allergy and clinical immunology. In practice
  • 2015
Update on the Management of Aspirin-Exacerbated Respiratory Disease
TLDR
The current standard approaches to the management of AERD are discussed, several therapeutics under development that may hold promise for the treatment of A ERD are introduced, and several therapeutic candidates under development are introduced.
A novel treatment adjunct for aspirin exacerbated respiratory disease: the low‐salicylate diet: a multicenter randomized control crossover trial
Aspirin‐exacerbated respiratory disease (AERD) is a clinical triad consisting of aspirin/acetylsalicylic acid (ASA) sensitivity, bronchial asthma, and nasal polyposis. Although respiratory reactions
Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis
TLDR
Current diagnostic and treatment strategies for aspirin-exacerbated diseases remain limited, and continued research focusing on each of the unique hypersensitivity reactions to aspirin is essential to advance the understanding of these disease processes.
...
1
2
3
...

References

SHOWING 1-10 OF 46 REFERENCES
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Role of aspirin desensitization in the management of chronic rhinosinusitis
  • H. Rizk
  • Medicine, Biology
    Current opinion in otolaryngology & head and neck surgery
  • 2011
TLDR
Oral and endonasal aspirin desensitization show positive impact on CRSwNP course with decreased polyp recurrence, decreased number of hospitalizations, and decreased need for corticosteroids.
Natural history of aspirin‐induced asthma
TLDR
There is a subset of patients with bronchial asthma who are susceptible to disease exacerbation upon receiving aspirin and other nonsteroidal anti-inflammatory drugs, associated with alterations in arachidonate metabolism and cysteinyl-leukotriene overproduction, which develops in a similar characteristic way all over Europe.
Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease.
TLDR
The highly selective COX-2 inhibitor etoricoxib was tolerated in most but not all patients tested, and an oral provocation test is recommended before prescribing etoricxib for patients with AERD.
Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
TLDR
This review article focuses on the management of AERD patients with a particular emphasis on aspirin desensitization and continuous treatment with aspirin.
Aspirin intolerance: does desensitization alter the course of the disease?
Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma.
TLDR
There is a subset of patients with bronchial asthma who are susceptible to disease exacerbation upon receiving aspirin and other nonsteroidal anti-inflammatory drugs, associated with alterations in arachidonate metabolism and cysteinyl-leukotriene overproduction, which develops in a similar characteristic way all over Europe.
Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma.
Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management.
TLDR
Aspirin desensitization, followed by daily aspirin treatment, is a valuable therapeutic option in most patients with AIA, particularly those with recurrent nasal polyposis or overdependence on systemic corticosteroids.
Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease.
TLDR
Patients with severe or poorly controlled asthma may experience asthma attacks even if using selective COX-2 inhibitors, however, treatment with steroids and an LTRAs may inhibit asthma attacks induced by celecoxib.
...
1
2
3
4
5
...